Culture-proven osteoarticular mycoses: an eight-year single-center descriptive study of fungal distribution and antifungal susceptibility trends
To describe the mycological profile of culture-proven osteoarticular mycoses (OAM) at a
5400-bed university hospital (2017–2024) according to clinical syndromes and assess
antifungal resistance trends.
